Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Chengdu
Clinical trial register · China

Clinical Trials in Chengdu, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Guangzhou 2 Beijing 1 Foshan 1 Wuhan 1 Shanghai 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
West China Hospital160 AstraZeneca154 Janssen Research & Development, LLC58 Eli Lilly and Company45 Hoffmann-La Roche44 Sichuan University39 Sanofi27 University of Electronic Science and Technology of China26 Boehringer Ingelheim23 Novartis Pharmaceuticals19 GlaxoSmithKline18 Sichuan Cancer Hospital and Research Institute17 Sichuan Provincial People's Hospital17 Daiichi Sankyo15 West China Second University Hospital14 Sichuan Baili Pharmaceutical Co., Ltd.13 Sun Yat-sen University10 Chengdu Zenitar Biomedical Technology Co., Ltd10 Gilead Sciences9 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.8 The General Hospital of Western Theater Command7 AbbVie7 Second Affiliated Hospital, Zhejiang University, School of Medicine7 Ruijin Hospital6 Sichuan Academy of Medical Sciences6 Merck Sharp & Dohme LLC6 Alexion Pharmaceuticals, Inc.6 Changchun GeneScience Pharmaceutical Co., Ltd.6 UCB Biopharma SRL6 Jiangsu HengRui Medicine Co., Ltd.6 Chengdu University of Traditional Chinese Medicine6 Pfizer6 The Third People's Hospital of Chengdu5 Bristol-Myers Squibb5 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.5 Chengdu Jinjiang Maternity and Child Health Hospital5 Dizal Pharmaceuticals5 Nanjing Medical University5 Suzhou Suncadia Biopharmaceuticals Co., Ltd.4 Xiamen Amoytop Biotech Co., Ltd.4 Amgen4 Shandong Suncadia Medicine Co., Ltd.4 Children's Cancer Group, China4 BioNTech SE4 Beijing GoBroad Hospital4 Akeso4 Du Zhenggui4 Guangdong Hengrui Pharmaceutical Co., Ltd4 Biotheus Inc.4 Chinese University of Hong Kong4 Xingchen Peng4 Beijing QL Biopharmaceutical Co.,Ltd3 Abbisko Therapeutics Co, Ltd3 Hangzhou Endonom Medtech Co., Ltd.3 Beijing InnoCare Pharma Tech Co., Ltd.3 Xiamen University3 Haisco Pharmaceutical Group Co., Ltd.3 Huashan Hospital3 Fudan University3 Tianjin Medical University Cancer Institute and Hospital3 Institute of Hematology & Blood Diseases Hospital, China3 argenx3 iCell Gene Therapeutics3 Takeda3 Chigenovo Co., Ltd3 Shenzhen Fosun Kairos Biotechnology Co., Ltd.3 Shanghai Pharmaceuticals Holding Co., Ltd3 Shanghai Jiaolian Drug Research and Development Co., Ltd3 BeOne Medicines3 Chengdu Ucello Biotechnology Co., Ltd.3 RemeGen Co., Ltd.3 Wang Xin3 Shanghai MicroPort CardioFlow Medtech Co., Ltd.3 Jiyan Liu3 Xijing Hospital3 Otsuka Pharmaceutical Development & Commercialization, Inc.2 Peking Union Medical College Hospital2 Celgene2 Harbin Medical University2 Changhai Hospital2 Meng Qiu2 H. Lundbeck A/S2 ScinnoHub Pharmaceutical Co., Ltd.2 Hinova Pharmaceuticals Inc.2 Peking University People's Hospital2 Incyte Corporation2 Nuvation Bio Inc.2 Avistone Biotechnology Co., Ltd.2 Nanfang Hospital, Southern Medical University2 Sinocelltech Ltd.2 Chunshui He2 Grit Biotechnology2 The Eye Hospital of Wenzhou Medical University2 Beijing Friendship Hospital2 Haihe Biopharma Co., Ltd.2 Beijing Biostar Pharmaceuticals Co., Ltd.2 CStone Pharmaceuticals2 Jie Li2 Sichuan Enray Pharmaceutical Sciences Company2 The First Affiliated Hospital with Nanjing Medical University2 Bo Wu2 Galderma R&D2 Juventas Cell Therapy Ltd.2 Shuangyue Liu2 Shanghai MicroPort EP MedTech Co., Ltd.2 Alnylam Pharmaceuticals2 Acerta Pharma BV2 Beijing Anzhen Hospital2 Novo Nordisk A/S2 EMD Serono Research & Development Institute, Inc.2 Xynomic Pharmaceuticals, Inc.2 Colgate Palmolive2 Peking University Third Hospital2 Tasly Pharmaceutical Group Co., Ltd2 Astellas Pharma Global Development, Inc.2 Southeast University, China2 Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology2 Tang-Du Hospital2 WestVac Biopharma Co., Ltd.2 Xinjiang Medical University2 Shanghai Henlius Biotech2 Beijing VDJBio Co., LTD.2 Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.2 Jazz Pharmaceuticals2 Cancer Institute and Hospital, Chinese Academy of Medical Sciences2 Huazhong University of Science and Technology2 Hutchmed2 Genmab2 Guangzhou Sinogen Pharmaceutical Co., Ltd2 Keymed Biosciences Co.Ltd2 Aragon Pharmaceuticals, Inc.2 Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.2 SightGlass Vision, Inc.2 MediLink Therapeutics (Suzhou) Co., Ltd.1 The George Institute1 CytoCares Inc1 Dimerix Bioscience Pty Ltd1 Guohui Xu1 Hong Wu1 Children's Hospital of Fudan University1 Xiao Wang1 Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd.1 Wen Tianfu1 Pierre Fabre Medicament1 Xuanwu Hospital, Beijing1 The Children's Hospital of Zhejiang University School of Medicine1 ADC Therapeutics S.A.1 First Hospital of China Medical University1 Intuitive Surgical1 Fujian Cancer Hospital1 Guangzhou Burning Rock Dx Co., Ltd.1 Vifor Fresenius Medical Care Renal Pharma1 Suzhou HepaThera Biotech Co., Ltd.1 Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.1 Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.1 Betta Pharmaceuticals Co., Ltd.1 InventisBio Co., Ltd1 Sichuan Clover Biopharmaceuticals, Inc.1 Ming Liu1 Peking University First Hospital1 Qilu Pharmaceutical Co., Ltd.1 IBSA Farmaceutici Italia Srl1 Viatris Innovation GmbH1 Aligos Therapeutics1 Zenas BioPharma (USA), LLC1 ImmuneOnco Biopharmaceuticals (Shanghai) Inc.1 Yingyong Zhou,MD,PhD1 Kun Sun1 Genuine Seed Therapeutics (Zhuhai) Co., Ltd.1 Hangzhou Sumgen Biotech Co., Ltd.1 CSL Behring1 Wayshine Biopharm, Inc.1 Integra LifeSciences Corporation1 Shenzhen Salubris Pharmaceuticals Co., Ltd.1 GeneCradle Inc1 Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd1 Weiwei Zhang1 Beijing Tiantan Hospital1 HitGen Inc.1 Suzhou BlueHorse Therapeutics Co., Ltd.1 CARsgen Therapeutics Co., Ltd.1 Beijing Pins Medical Co., Ltd1 Xi Wu1 Shanghai Juncell Therapeutics1 Jia Fan1 Medtronic1 Epygenix1 Edwards Lifesciences1 OriCell Therapeutics Co., Ltd.1 Hangzhou Highlightll Pharmaceutical Co., Ltd1 LEO Pharma1 Hao Zeng1 a2 Milk Company Ltd.1 ExoRNA Bioscience1 Servier (Tianjin) Pharmaceutical Co. LTD.1 DualityBio Inc.1 Shanghai UniXell Biotechnology Co., Ltd1 Xi Cao1 Shanghai Synvida Biotechnology Co.,Ltd.1 Innostellar Biotherapeutics Co.,Ltd1 Yanyan Liu1 The First Affiliated Hospital of Zhengzhou University1 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1 Ipsen1 Peking University1 Zhongda Hospital1 Cloudbreak Therapeutics, LLC1 Hasten Biopharmaceutical Co., Ltd.1 Actelion1 Karyopharm Therapeutics Inc1 MAXVAX Biotechnology Limited Liability Company1 Merz North America, Inc.1 Ausper Biopharma Co., Ltd.1 Chongqing Jinsaixing Medical Technology Co., Ltd1 Shanghai Bovax Biotechnology Co., Ltd.1 Cytocraft Biopharmaceutical Co., Ltd.1 Nanjing IASO Biotechnology Co., Ltd.1 Sichuan Huiyu Pharmaceutical Co., Ltd1 Yu Feng1 Fujian Shengdi Pharmaceutical Co., Ltd.1 Dizal (Jiangsu) Pharmaceutical Co., Ltd.1 Second Xiangya Hospital of Central South University1 Shanghai Institute Of Biological Products1 MedtronicNeuro1 Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.1 Servier Bio-Innovation LLC1 Yi Ji1 Sinovac Biotech Co., Ltd1 Lei Liu1 Zhengzhou Children's Hospital, China1 Geneplus-Beijing Co. Ltd.1 Chinese Academy of Sciences1 Heilongjiang Feihe Dairy Co. Ltd.1 InnoCare Pharma Inc.1 Xijing Hospital of Digestive Diseases1 HighField Biopharmaceuticals Corporation1 Belite Bio, Inc1 Zhao Siyao1 Singlera Genomics Inc.1 Zai Lab (Shanghai) Co., Ltd.1 Acepodia Biotech, Inc.1 The University of Texas Health Science Center, Houston1 Turun Song1 Institut de Recherches Internationales Servier1 CSPC ZhongQi Pharmaceutical Technology Co., Ltd.1 Mabwell (Shanghai) Bioscience Co., Ltd.1 Tingting Luo1 Yuju Wu1 Shanghai Tong Ren Hospital1 Simcere Pharmaceutical Co., Ltd1 Ractigen Therapeutics.1 Shanghai Mabgen Biopharmaceutical Technology Co., Ltd.1 Sound Biopharmaceuticals Ltd.1 Zhejiang Cancer Hospital1 Qiang Hu1 Shanghai Changzheng Hospital1 Dianthus Therapeutics1 Ion Beam Applications1 Beijing Kanghong Biopharmaceutical Co., Ltd.1 Evopoint Biosciences Inc.1 Fan Zeng1 Kexing Biopharm Co., Ltd.1 Hangzhou Broncus Medical Co., Ltd.1 Biohaven Pharmaceuticals, Inc.1 Huabo Biopharm Co., Ltd.1 You Lu1 Shanghai Haiyan Pharmaceutical Technology Co., Ltd.1 Beijing 302 Hospital1 RenJi Hospital1 Shanghai Chest Hospital1 Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.1 Second Affiliated Hospital of Xi'an Jiaotong University1 Lifetech Scientific (Shenzhen) Co., Ltd.1 Chengdu CoenBiotech Co., Ltd1 Innovent Biologics Technology Limited (Shanghai R&D Center)1 Chengdu FenDi Pharmaceutical Co., Ltd.1 Chengdu Sport University1 Ding Ke-Feng1 Bayer1 Eye & ENT Hospital of Fudan University1 NeuShen Therapeutics1 Shanghai Argo Biopharmaceutical Co., Ltd.1 Cullgen (Shanghai),Inc1 D3 Bio (Wuxi) Co., Ltd1 Alpine Immune Sciences Inc, A Subsidiary of Vertex1 TransThera Sciences (Nanjing), Inc.1 Yong Zhou1 MSD R&D (China) Co., Ltd.1 Chinese Academy of Medical Sciences, Fuwai Hospital1 Beijing University of Chinese Medicine1 Chengdu New Radiomedicine Technology Co. LTD.1 Chongqing Claruvis Pharmaceutical Co., Ltd.1 Lu Wang1 Shanghai Auzone Biological Technology Co., Ltd.1 Jiangsu Simcere Pharmaceutical Co., Ltd.1 Biotech Pharmaceutical Co., Ltd.1 Candid Therapeutics1 Jecho Biopharmaceuticals Co., Ltd.1 First Affiliated Hospital of Chengdu Medical College1 Chengdu Qingshan Likang Pharmaceutical Co., Ltd1 Juan LI, MD1 Salubris Biotherapeutics Inc1 Fujian Medical University Union Hospital1 The Hong Kong Polytechnic University1 National Cancer Centre, Singapore1 The Third Affiliated Hospital of Guangzhou Medical University1 Aimei Vacin BioPharm (Zhejiang) Co., Ltd.1 Bellus Health Inc. - a GSK company1 Nanjing Leads Biolabs Co.,Ltd1 LeonaBio1 ChromX Health1 TJ Biopharma Co., Ltd.1 Guangdong Association of Clinical Trials1 Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.1 Ahon Pharmaceutical Co., Ltd.1 Vantive Health LLC1 Hangzhou DAC Biotechnology Co., Ltd.1 Chengdu Suncadia Medicine Co., Ltd.1 Multitude Therapeutics Inc.1 Medtronic Cardiac Ablation Solutions1 Shanghai Shangyang Medical Technology Co., Ltd.1 Chinese Academy of Medical Sciences1 Colorado Prevention Center1 ChunBao Li1 CLASSYS Inc.1 Southwest Hospital, China1 Vertex Pharmaceuticals Incorporated1 Zhuhai Yufan Biotechnologies Co., Ltd1 Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.1 Shanghai Zhongshan Hospital1 Servier1 Johnson & Johnson Enterprise Innovation Inc.1 Jemincare1 Ascentage Pharma Group Inc.1 Guiquan Zhu1 Ke Dou1 Basilea Pharmaceutica1 Shanghai Huilun Pharmaceutical Co., Ltd.1 Antengene Biologics Limited1 Zhejiang Yangli Pharmaceutical Technology Co., Ltd.1 Boston Scientific Corporation1 Shanghai Jiao Tong University School of Medicine1 Chipscreen Biosciences, Ltd.1 Johnson & Johnson Medical (Shanghai) Ltd.1 Taiho Oncology, Inc.1 Jiayuan Sun1 Hejiang Ye1 Beijing Sungen Biomedical Technology Co., Ltd1 Medtronic Cardiovascular1 Beckman Coulter, Inc.1 Hangzhou Valgen Medtech Co., Ltd1 Chunling Jiang1 Guangzhou University of Traditional Chinese Medicine1 R1 Therapeutics1 City University of Hong Kong1 Medtronic Spinal and Biologics1 Gang Wang1 InnoVec Biotherapeutics Inc.1 Mundipharma (China) Pharmaceutical Co. Ltd1 Suzhou Sanegene Bio Inc.1 Abbott Medical Devices1 China National Center for Cardiovascular Diseases1 Beijing Hospital of Traditional Chinese Medicine1 Xuelei Ma MD1 Lu Jiang1 Jie Zhong1 Kylonova (Xiamen) Biopharma co., LTD.1 Medolution Ltd.1 Brii Biosciences Limited1 Suzhou Forlong Biotechnology Co., Ltd1 First Affiliated Hospital Xi'an Jiaotong University1 Zhejiang Haichang Biotech Co., Ltd.1 Clear sponsor filter
Site location
Guangzhou2 Beijing1 Foshan1 Wuhan1 Shanghai1 Chengdu1
All 6 locations
Target enrolment
to

Trials with a site in Chengdu

1 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Differentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled Breath
NCT06518655Pulmonary Nodules, Multiple, Pulmonary Nodules, Solitary, Lung Cancer
ChromX Health
Observational
3,000
Beijing, Foshan, Guangzhou, Wuhan, Shanghai, Chengdu
2024-06-30
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/chengdu

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies with a site in Chengdu that also match the filters currently applied.

How many clinical trials are recruiting in Chengdu?

1 of the 1 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Chengdu), 1 studies
PhaseStudiesRecruitingShare
Observational11100%

Most active sponsors

Lead sponsors with the most studies (Chengdu)
Lead sponsorStudiesRecruiting
ChromX Health11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.